Skip to main content

Peer Review reports

From: Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor

Original Submission
12 Aug 2015 Submitted Original manuscript
23 Oct 2015 Author responded Author comments - Toshio Nishimura
1 Sep 2015 Reviewed Reviewer Report - Janice Monteiro
20 Aug 2015 Reviewed Reviewer Report - Koji Matsuo
Resubmission - Version 2
23 Oct 2015 Submitted Manuscript version 2
24 Nov 2015 Author responded Author comments - Toshio Nishimura
Resubmission - Version 3
24 Nov 2015 Submitted Manuscript version 3
Publishing
5 Dec 2015 Editorially accepted
16 Dec 2015 Article published 10.1186/s12885-015-1975-5

You can find further information about peer review here.

Back to article page